These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 33037808)

  • 1. Effectiveness of salivary stimulation using xylitol-malic acid tablets as coadjuvant treatment in patients with gastro-oesophageal reflux disease: early findings.
    Sánchez-Blanco I; Rodríguez-Téllez M; Corcuera-Flores JR; González-Blanco C; Torres-Lagares D; Serrera-Figallo MÁ; Machuca-Portillo G
    Med Oral Patol Oral Cir Bucal; 2020 Nov; 25(6):e818-e826. PubMed ID: 33037808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of gustatory stimulants of salivary secretion on salivary pH and flow in patients with Sjögren's syndrome: a randomized controlled trial.
    da Silva Marques DN; da Mata AD; Patto JM; Barcelos FA; de Almeida Rato Amaral JP; de Oliveira MC; Ferreira CG
    J Oral Pathol Med; 2011 Nov; 40(10):785-92. PubMed ID: 21481003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dental erosion, gastro-oesophageal reflux disease and saliva: how are they related?
    Moazzez R; Bartlett D; Anggiansah A
    J Dent; 2004 Aug; 32(6):489-94. PubMed ID: 15240067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of 1% malic acid spray on the oral health-related quality of life of patients with xerostomia.
    Niklander S; Fuentes F; Sanchez D; Araya V; Chiappini G; Martinez R; Marshall M
    J Oral Sci; 2018; 60(2):278-284. PubMed ID: 29925712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pepsin in saliva for the diagnosis of gastro-oesophageal reflux disease.
    Hayat JO; Gabieta-Somnez S; Yazaki E; Kang JY; Woodcock A; Dettmar P; Mabary J; Knowles CH; Sifrim D
    Gut; 2015 Mar; 64(3):373-80. PubMed ID: 24812000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the efficacy of a topical sialogogue spray containing malic acid 1% in elderly people with xerostomia: a double-blind, randomized clinical trial.
    Gómez-Moreno G; Cabrera-Ayala M; Aguilar-Salvatierra A; Guardia J; Ramírez-Fernández MP; González-Jaranay M; Calvo-Guirado JL
    Gerodontology; 2014 Dec; 31(4):274-80. PubMed ID: 23294350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of gastro-oesophageal reflux disease with upper gastrointestinal symptoms without heartburn and regurgitation.
    Vakil N; Wernersson B; Ohlsson L; Dent J
    United European Gastroenterol J; 2014 Jun; 2(3):173-8. PubMed ID: 25360300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond heartburn: a systematic review of the extra-oesophageal spectrum of reflux-induced disease.
    Hungin AP; Raghunath AS; Wiklund I
    Fam Pract; 2005 Dec; 22(6):591-603. PubMed ID: 16024554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of potent acid inhibition in gastro-oesophageal reflux disease.
    Monés J
    Drugs; 2005; 65 Suppl 1():35-42. PubMed ID: 16335856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of acute and chronic administration of the GABA B agonist baclofen on 24 hour pH metry and symptoms in control subjects and in patients with gastro-oesophageal reflux disease.
    Ciccaglione AF; Marzio L
    Gut; 2003 Apr; 52(4):464-70. PubMed ID: 12631652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Release of cariostatic agents from a new buffering fluoride- and xylitol-containing lozenge to human whole saliva in vivo.
    Tenovuo J; Hurme T; Ahola A; Svedberg C; Ostela I; Lenander-Lumikari M; Neva M
    J Oral Rehabil; 1997 May; 24(5):325-31. PubMed ID: 9183024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence of dental erosion in Nigerian patients with gastro-oesophageal reflux disease.
    Oginni AO; Agbakwuru EA; Ndububa DA
    BMC Oral Health; 2005 Mar; 5(1):1. PubMed ID: 15740613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the GABA(B) agonist baclofen in patients with symptoms and duodeno-gastro-oesophageal reflux refractory to proton pump inhibitors.
    Koek GH; Sifrim D; Lerut T; Janssens J; Tack J
    Gut; 2003 Oct; 52(10):1397-402. PubMed ID: 12970129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Lactobacillus salivarius-containing tablets on caries risk factors: a randomized open-label clinical trial.
    Nishihara T; Suzuki N; Yoneda M; Hirofuji T
    BMC Oral Health; 2014 Sep; 14():110. PubMed ID: 25178882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastro-oesophageal reflux - an important causative factor of severe tooth wear in Prader-Willi syndrome?
    Saeves R; Strøm F; Sandvik L; Nordgarden H
    Orphanet J Rare Dis; 2018 Apr; 13(1):64. PubMed ID: 29685165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of regurgitation on health-related quality of life in gastro-oesophageal reflux disease before and after short-term potent acid suppression therapy.
    Kahrilas PJ; Jonsson A; Denison H; Wernersson B; Hughes N; Howden CW
    Gut; 2014 May; 63(5):720-6. PubMed ID: 23831734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-related outcomes in Sjögren syndrome treated with stimulants of salivary secretion: Randomized clinical trial.
    da Mata ADSP; Amaral JPAR; Thomson WM; Barcelos F; Vaz Patto J; Pereira RMN; Marques DNDS
    Oral Dis; 2020 Mar; 26(2):313-324. PubMed ID: 31814226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of treatment for gastro-oesophageal reflux disease on health-related quality of life: a literature review.
    Prasad M; Rentz AM; Revicki DA
    Pharmacoeconomics; 2003; 21(11):769-90. PubMed ID: 12859219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of gustatory stimulants of salivary secretion on salivary pH and flow: a randomized controlled trial.
    da Mata AD; da Silva Marques DN; Silveira JM; Marques JR; de Melo Campos Felino ET; Guilherme NF
    Oral Dis; 2009 Apr; 15(3):220-8. PubMed ID: 19220764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of xylitol chewing gum on salivary flow rate, pH, buffering capacity and presence of Streptococcus mutans in saliva.
    Ribelles Llop M; Guinot Jimeno F; Mayné Acién R; Bellet Dalmau LJ
    Eur J Paediatr Dent; 2010 Mar; 11(1):9-14. PubMed ID: 20359274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.